Dongxia Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dongxia Zhu has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
- Martin Robert Bryce
Department of Chemistry Durham University Durham UK
38 shared publications - Zhong-Min Su
Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education Hainan Normal University Haikou China
28 shared publications Guangfu Li
Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Department of Chemistry, Northeast Normal University, 5268 Renmin Street, Changchun, Jilin 130024, P. R. China
18 shared publicationsWeilong Che
Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Department of Chemistry, Northeast Normal University, Changchun, P. R. China
11 shared publicationsZiwei Wang
Department of Neurology, Institute of Translational Medicine
11 shared publications- Ben Zhong Tang
The Hong Kong University of Science and Technology Clear Water Bay
10 shared publications
Latest Publications
- 11 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (71) , 17557-17571
Harnessing aggregation-induced emission-active fluorescent probes to illuminate intracellular metal ions
Focusing on intracellular imaging, this review systematizes AIE probe designs for essential/toxic metal ions and multiplexed detection, charting a path from chemical sensing to biological insight.
- 11 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (71) , 17557-17571
Harnessing aggregation-induced emission-active fluorescent probes to illuminate intracellular metal ions
Focusing on intracellular imaging, this review systematizes AIE probe designs for essential/toxic metal ions and multiplexed detection, charting a path from chemical sensing to biological insight.
- 20 February 2026
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 8 (5) , 3827-3842
Near-Infrared Chemiluminescence Supramolecular Porphyrin Hydrogel Containing Fe/Mn Double Transition Metals for Wound Healing
- 20 February 2026
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 8 (5) , 3827-3842
Near-Infrared Chemiluminescence Supramolecular Porphyrin Hydrogel Containing Fe/Mn Double Transition Metals for Wound Healing
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
Crosslinker-Free PVA Hydrogel Incorporating a Water-Soluble Ir(III) Photosensitizer for Antibacterial Photodynamic Applications in Wound Healing
Bacterial infection, particularly those involving biofilm formation and antibiotic-resistant pathogens, severely impede wound healing. Photodynamic antibacterial therapy (PDT) offers a non-antibiotic, broad-spectrum antibacterial strategy via lighttriggered reactive oxygen species (ROS)...
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
Crosslinker-Free PVA Hydrogel Incorporating a Water-Soluble Ir(III) Photosensitizer for Antibacterial Photodynamic Applications in Wound Healing
Bacterial infection, particularly those involving biofilm formation and antibiotic-resistant pathogens, severely impede wound healing. Photodynamic antibacterial therapy (PDT) offers a non-antibiotic, broad-spectrum antibacterial strategy via lighttriggered reactive oxygen species (ROS)...
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Endogenous near-infrared chemiluminescent manganese ion-driven porphyrin supramolecular platform for the theranostics of thrombosis and ischemic stroke
Mn-Ce6@R NPs enable ONOO − -responsive NIR chemiluminescence imaging-guided PTT/PDT thrombolysis and RONS-scavenging neuroprotection for ischemic stroke.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessEndogenous near-infrared chemiluminescent manganese ion-driven porphyrin supramolecular platform for the theranostics of thrombosis and ischemic stroke
Mn-Ce6@R NPs enable ONOO − -responsive NIR chemiluminescence imaging-guided PTT/PDT thrombolysis and RONS-scavenging neuroprotection for ischemic stroke.
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (24) , 12120-12132
Dual RONS-responsive chemiluminescence-guided multimodal thrombolysis based on an aggregation-induced emission cobalt-porphyrin nanoplatform
A cobalt-porphyrin nanoplatform with chemiluminescence imaging for multimodal thrombolysis is reported. Co2Ir NPs exert antioxidant effects and prevent secondary embolism.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (24) , 12120-12132
Open AccessDual RONS-responsive chemiluminescence-guided multimodal thrombolysis based on an aggregation-induced emission cobalt-porphyrin nanoplatform
A cobalt-porphyrin nanoplatform with chemiluminescence imaging for multimodal thrombolysis is reported. Co2Ir NPs exert antioxidant effects and prevent secondary embolism.
- Open Access
- 4 November 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (89) , 17400-17403
AIE Ir( iii ) complex conjugated with biotin as a photosensitizer for enhanced photodynamic anticancer therapy
An aggregation induced emission (AIE) Ir( iii ) complex bearing a biotin-functionalized ligand, Ir-Bio, generates type I and type II reactive oxygen species and easily enters cancer cells where it has an excellent photodynamic therapy effect.
- 4 November 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (89) , 17400-17403
Open AccessAIE Ir( iii ) complex conjugated with biotin as a photosensitizer for enhanced photodynamic anticancer therapy
An aggregation induced emission (AIE) Ir( iii ) complex bearing a biotin-functionalized ligand, Ir-Bio, generates type I and type II reactive oxygen species and easily enters cancer cells where it has an excellent photodynamic therapy effect.
- Open Access
- 5 October 2025
- Published by Wiley in Advanced Science
- Vol. 12 (47) , e15079
A Metalloporphyrin Nanosystem Enables Non‐Invasive Visualization and Specific Treatment for Thrombosis and Ischemic Stroke
Thrombotic ischemic stroke (IS) is a severe neurological disease of the brain, with high global mortality and disability rates. The significant temporal disconnect and lack of coordination between thrombolysis (≥15% hemorrhage risk from short half‐life thrombolytics) and IS treatment results in limited clinical efficacy. Innovative strategies are required to: 1) resolve stereochemical conflicts in single‐molecule multifunctional materials; 2) enable spatiotemporal functions for effective diagnosis and treatment; 3) establish unambiguous structure‐property relationships. Herein, 4IrMn nanoparticles (NPs), with a dual transition metal core exhibit an endogenous peroxynitrite (ONOO − ) response, which triggers near‐infrared chemiluminescence (NIR‐CL) signals for the precise location of lesion sites. Under laser irradiation, 4IrMn NPs initiate synergistic photothermal therapy (PTT) and photodynamic therapy (PDT) in mouse thrombus models to achieve effective thrombolysis (the relative volume of clots decreased by ≈60%) with no observed hemorrhagic complications or recurrent embolism. After thrombolysis, 4IrMn NPs effectively scavenge excess cytotoxic reactive oxygen/nitrogen species (RONS) and suppresses pro‐inflammatory cytokines such as tumor necrosis factor‐alpha/interleukin‐6 (TNF‐α and IL‐6). Ultimately, 4IrMn NPs enhance neuronal survival in the ischemic penumbra and reduce the extent of cerebral tissue death. This single‐molecule‐based multifunctional nanosystem integrates diagnostic‐therapeutic‐prognosis features, realizing a significant advance in addressing the constraints of current thrombosis and IS treatment.
- 5 October 2025
- Published by Wiley in Advanced Science
- Vol. 12 (47) , e15079
Open AccessA Metalloporphyrin Nanosystem Enables Non‐Invasive Visualization and Specific Treatment for Thrombosis and Ischemic Stroke
Thrombotic ischemic stroke (IS) is a severe neurological disease of the brain, with high global mortality and disability rates. The significant temporal disconnect and lack of coordination between thrombolysis (≥15% hemorrhage risk from short half‐life thrombolytics) and IS treatment results in limited clinical efficacy. Innovative strategies are required to: 1) resolve stereochemical conflicts in single‐molecule multifunctional materials; 2) enable spatiotemporal functions for effective diagnosis and treatment; 3) establish unambiguous structure‐property relationships. Herein, 4IrMn nanoparticles (NPs), with a dual transition metal core exhibit an endogenous peroxynitrite (ONOO − ) response, which triggers near‐infrared chemiluminescence (NIR‐CL) signals for the precise location of lesion sites. Under laser irradiation, 4IrMn NPs initiate synergistic photothermal therapy (PTT) and photodynamic therapy (PDT) in mouse thrombus models to achieve effective thrombolysis (the relative volume of clots decreased by ≈60%) with no observed hemorrhagic complications or recurrent embolism. After thrombolysis, 4IrMn NPs effectively scavenge excess cytotoxic reactive oxygen/nitrogen species (RONS) and suppresses pro‐inflammatory cytokines such as tumor necrosis factor‐alpha/interleukin‐6 (TNF‐α and IL‐6). Ultimately, 4IrMn NPs enhance neuronal survival in the ischemic penumbra and reduce the extent of cerebral tissue death. This single‐molecule‐based multifunctional nanosystem integrates diagnostic‐therapeutic‐prognosis features, realizing a significant advance in addressing the constraints of current thrombosis and IS treatment.
- Open Access
- 12 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (18) , 12337-12344
Non-Traditional Luminescent Polyurethanes of n–π Electron Hybrid Structures with Varying Separation of Aromatic Rings
Detailed structure–activity relationships and molecular design criteria for nonconventional and nonconjugated luminescent polymers are still ambiguous. This work reports n–π electron hybrid polyurethane derivatives (PUs) with varying separation of benzene rings in the backbone. Experimental and computational results show that although through-bond conjugation is not the main source of luminescence, the separated benzene rings still modulate the photophysical properties by affecting the molecular conformation and electron transport. Meanwhile, hydrogen bonds and p–π* interactions exert a significant influence on the emission wavelengths by regulating the aggregated-state structures. In PU1, the excited state is predominantly charge transfer. With an increase in the number of benzene rings along the chain, the energy gap between the acceptor π and π* orbitals is reduced; alongside these effects, the modulation from hydrogen bonds and p–π* interactions promotes a transition to LE-dominated states in PU3, which incorporates terphenyl units. Proof-of-concept applications are demonstrated in information transmission and colorful displays. This work enhances the understanding of the mechanisms underlying the excitation-dependent properties of nonconventional polymers and provides a strategy for tuning and exploiting their intrinsic luminescence.
- 12 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Polymer Materials
- Vol. 7 (18) , 12337-12344
Open AccessNon-Traditional Luminescent Polyurethanes of n–π Electron Hybrid Structures with Varying Separation of Aromatic Rings
Detailed structure–activity relationships and molecular design criteria for nonconventional and nonconjugated luminescent polymers are still ambiguous. This work reports n–π electron hybrid polyurethane derivatives (PUs) with varying separation of benzene rings in the backbone. Experimental and computational results show that although through-bond conjugation is not the main source of luminescence, the separated benzene rings still modulate the photophysical properties by affecting the molecular conformation and electron transport. Meanwhile, hydrogen bonds and p–π* interactions exert a significant influence on the emission wavelengths by regulating the aggregated-state structures. In PU1, the excited state is predominantly charge transfer. With an increase in the number of benzene rings along the chain, the energy gap between the acceptor π and π* orbitals is reduced; alongside these effects, the modulation from hydrogen bonds and p–π* interactions promotes a transition to LE-dominated states in PU3, which incorporates terphenyl units. Proof-of-concept applications are demonstrated in information transmission and colorful displays. This work enhances the understanding of the mechanisms underlying the excitation-dependent properties of nonconventional polymers and provides a strategy for tuning and exploiting their intrinsic luminescence.
- Open Access
- 10 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (39) , e2503599
Sonodynamic and Bioorthogonal Sonocatalytic Thrombotic Therapy Based on AIE Cationic Tetranuclear Ir(III) Complex Nanoplatform Guided by NIR‐Chemiluminescence Imaging
Non‐invasive thrombolytic strategies include photothermal therapy (PTT), photodynamic therapy (PDT) and sonodynamic therapy (SDT). The development of PTT and PDT is impeded by the limited tissue penetration depth of the light source. SDT is a promising method due to the deeper tissue penetration and site‐specific features of ultrasound; however, the scarcity of efficient sonosensitizers has constrained its clinical use. Herein, ultrasound‐triggered nanoparticles (NPs), named Ir‐4@S‐R NPs, achieve a sonodynamic thrombolytic, bioorthogonal sonocatalytic reaction, with chemiluminescence (CL) imaging in the thrombus. An Ir(III) complex, named Ir‐4, which has aggregation induced emission (AIE), combined with a hydrogen sulfide donor, named H 2 S‐N 3 , provide the nanoplatform which is modified with the peptide c(RGDfC) to target the thrombus. This supramolecular assembly successfully integrates: i) thrombosis detection based on near‐infrared (NIR) chemiluminescence imaging, ii) sonodynamic thrombus therapy and iii) release of hydrogen sulfide for anti‐inflammatory action. Ir‐4@S‐R NPs emit long‐lasting NIR CL triggered by endogenous ONOO − and achieve 12 mm deep tissue penetration. Blood clots are effectively removed and blood flow is almost fully restored in mouse carotid thrombus and rat femoral vein models. The work demonstrates a new integrated strategy for diagnosing and treating life‐threatening diseases caused by thrombusotic disorders.
- 10 July 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (39) , e2503599
Open AccessSonodynamic and Bioorthogonal Sonocatalytic Thrombotic Therapy Based on AIE Cationic Tetranuclear Ir(III) Complex Nanoplatform Guided by NIR‐Chemiluminescence Imaging
Non‐invasive thrombolytic strategies include photothermal therapy (PTT), photodynamic therapy (PDT) and sonodynamic therapy (SDT). The development of PTT and PDT is impeded by the limited tissue penetration depth of the light source. SDT is a promising method due to the deeper tissue penetration and site‐specific features of ultrasound; however, the scarcity of efficient sonosensitizers has constrained its clinical use. Herein, ultrasound‐triggered nanoparticles (NPs), named Ir‐4@S‐R NPs, achieve a sonodynamic thrombolytic, bioorthogonal sonocatalytic reaction, with chemiluminescence (CL) imaging in the thrombus. An Ir(III) complex, named Ir‐4, which has aggregation induced emission (AIE), combined with a hydrogen sulfide donor, named H 2 S‐N 3 , provide the nanoplatform which is modified with the peptide c(RGDfC) to target the thrombus. This supramolecular assembly successfully integrates: i) thrombosis detection based on near‐infrared (NIR) chemiluminescence imaging, ii) sonodynamic thrombus therapy and iii) release of hydrogen sulfide for anti‐inflammatory action. Ir‐4@S‐R NPs emit long‐lasting NIR CL triggered by endogenous ONOO − and achieve 12 mm deep tissue penetration. Blood clots are effectively removed and blood flow is almost fully restored in mouse carotid thrombus and rat femoral vein models. The work demonstrates a new integrated strategy for diagnosing and treating life‐threatening diseases caused by thrombusotic disorders.
- Open Access
Constructing 1 + 1 > 2 Photosensitizers Based on NIR Cyanine–Iridium(III) Complexes for Enhanced Photodynamic Cancer Therapy
Photosensitizers with high singlet oxygen (1O2) generation capacity under near-infrared (NIR) irradiation are essential and challenging for photodynamic therapy (PDT). A simple yet effective molecular design strategy is realized to construct 1 + 1 > 2 photosensitizers with synergistic effects by covalently integrating iridium complexes with cyanine via ether linkages, as well as introducing aldehyde groups to suppress non-radiative decay, named CHO−Ir−Cy. It is demonstrated that CHO−Ir−Cy successfully maintains the NIR absorption and emission originated from cyanine units and high 1O2 generation efficiency from the iridium complex part, which gives full play to their respective advantages while compensating for shortcomings. Density functional theory (DFT) calculations reveal that CHO−Ir−Cy exhibits a stronger spin–orbit coupling constant (ξ (S1, T1) = 9.176 cm−1) and a reduced energy gap (ΔE = −1.97 eV) between triplet excited states (T1) and first singlet excited states (S1) compared to parent Ir−Cy or Cy alone, directly correlating with its enhanced 1O2 production. Remarkably, CHO−Ir−Cy demonstrates superior cellular internalization in 4T1 murine breast cancer cells, generating substantially elevated 1O2 yields compared to individual Ir−Cy/Cy under 808 nm laser irradiation. Such enhanced reactive oxygen species production translates into effective cancer cell ablation while maintaining favorable biocompatibility, significant phototoxicity and negligible dark toxicity. This molecular engineering strategy overcomes the inherent NIR absorption limitation of traditional iridium complexes and ensures their own high 1O2 generation ability through dye–metal synergy, establishing a paradigm for designing metal–organic photosensitizers with tailored photophysical properties for precision oncology.
Open AccessConstructing 1 + 1 > 2 Photosensitizers Based on NIR Cyanine–Iridium(III) Complexes for Enhanced Photodynamic Cancer Therapy
Photosensitizers with high singlet oxygen (1O2) generation capacity under near-infrared (NIR) irradiation are essential and challenging for photodynamic therapy (PDT). A simple yet effective molecular design strategy is realized to construct 1 + 1 > 2 photosensitizers with synergistic effects by covalently integrating iridium complexes with cyanine via ether linkages, as well as introducing aldehyde groups to suppress non-radiative decay, named CHO−Ir−Cy. It is demonstrated that CHO−Ir−Cy successfully maintains the NIR absorption and emission originated from cyanine units and high 1O2 generation efficiency from the iridium complex part, which gives full play to their respective advantages while compensating for shortcomings. Density functional theory (DFT) calculations reveal that CHO−Ir−Cy exhibits a stronger spin–orbit coupling constant (ξ (S1, T1) = 9.176 cm−1) and a reduced energy gap (ΔE = −1.97 eV) between triplet excited states (T1) and first singlet excited states (S1) compared to parent Ir−Cy or Cy alone, directly correlating with its enhanced 1O2 production. Remarkably, CHO−Ir−Cy demonstrates superior cellular internalization in 4T1 murine breast cancer cells, generating substantially elevated 1O2 yields compared to individual Ir−Cy/Cy under 808 nm laser irradiation. Such enhanced reactive oxygen species production translates into effective cancer cell ablation while maintaining favorable biocompatibility, significant phototoxicity and negligible dark toxicity. This molecular engineering strategy overcomes the inherent NIR absorption limitation of traditional iridium complexes and ensures their own high 1O2 generation ability through dye–metal synergy, establishing a paradigm for designing metal–organic photosensitizers with tailored photophysical properties for precision oncology.